Multiple Risk Factors in Cardiovascular Disease
Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke
Seiten
1998
Kluwer Academic Publishers (Verlag)
978-0-7923-5023-1 (ISBN)
Kluwer Academic Publishers (Verlag)
978-0-7923-5023-1 (ISBN)
A collection of the scientific contributions to the 4th International Symposium on Multiple Risk Factors and Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke.
The issue of interaction of risk factors in cardiovascular disease is discussed in this text which is a collection of the scientific contributions to the 4th International Symposium on Multiple Risk Factors and Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke. The book addresses the role of simultaneous risk factors in patients. Because patients with two or more risk factors are at very high risk for developing cardiovascular diseases, special care should be taken in the choice of appropriate therapeutic intervention. Risk factors are also discussed from the point of view of the biochemist and the pharmacologist by addressing the mechanisms underlying the onset of hypertension, hyperlipoproteinemia, hypercoagulability, and the possibility of therapeutic intervention. This book should therefore be of value to the biochemist, pharmacologist, and clinical pharmacologist, as well as to specialists in the field of cardiovascular medicine.
The issue of interaction of risk factors in cardiovascular disease is discussed in this text which is a collection of the scientific contributions to the 4th International Symposium on Multiple Risk Factors and Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke. The book addresses the role of simultaneous risk factors in patients. Because patients with two or more risk factors are at very high risk for developing cardiovascular diseases, special care should be taken in the choice of appropriate therapeutic intervention. Risk factors are also discussed from the point of view of the biochemist and the pharmacologist by addressing the mechanisms underlying the onset of hypertension, hyperlipoproteinemia, hypercoagulability, and the possibility of therapeutic intervention. This book should therefore be of value to the biochemist, pharmacologist, and clinical pharmacologist, as well as to specialists in the field of cardiovascular medicine.
I. Plasma Lipids and Lipoproteins. II. Coagulation, Fibrinolysis, and Platelet Inhibition. III. Emerging Risk Factors for Cardiovascular Disease. IV. Risk Factors and Intervention: National Initiatives. V. LDL Oxidation, Antioxidants, and Atherosclerosis. VI. Diabetes. VII. Genetic Determinants of Cardiovascular Disease. VIII. Inflammation and Cardiovascular Disease. IX. From Cholesterol to Cardiovascular Events, Where is the Bridge? X. Lifestyle and Cardiovascular Disease. XI. Multiple Risk Factors and Cardiovascular Disease. XII. Cardiac Failure.
| Erscheint lt. Verlag | 31.3.1998 |
|---|---|
| Reihe/Serie | Medical Science Symposia ; v. 12 |
| Zusatzinfo | index |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Gewicht | 726 g |
| Einbandart | gebunden |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
| ISBN-10 | 0-7923-5023-5 / 0792350235 |
| ISBN-13 | 978-0-7923-5023-1 / 9780792350231 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
in Fällen, Fragen und Antworten
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60
Diagnostik und interventionelle Therapie | 2 Bände
Buch (2024)
Deutscher Ärzteverlag
CHF 489,95
Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 61,60
